GANAB and Isolated polycystic liver disease: In polycystic liver disease, miR-345 has been shown to reduce proliferation, possibly by downregulating GluII subunits like GANAB which encodes the α-subunit, supporting the concept of post-transcriptional regulation as a selective therapeutic strategy [153].